Lean (codeine-promethazine cough syrup) can cause seizures, but almost never through the syrup itself in a person with a healthy brain. The seizure risk comes from three separate mechanisms: poisoning by promethazine or another adulterant, withdrawal from codeine or a contaminating opioid such as fentanyl, and indirect triggers like sleep deprivation during a binge. Toxicological reviews of promethazine overdose report seizures in roughly 1 to 10 percent of serious cases, usually after doses above 100 mg. For most users, the realistic danger is not the drink but the withdrawal state and the unknown additives.
How Lean Acts on the Brain
Lean is a mixture of codeine, an opioid, and promethazine, a sedating antihistamine. Both drugs depress the central nervous system, which is why the combination produces euphoria and heavy drowsiness. Codeine binds mu-opioid receptors and slows the electrical activity that governs breathing, alertness, and temperature control. Promethazine blocks histamine H1 receptors and also blocks acetylcholine and dopamine receptors at higher doses.
The seizure risk is not a straightforward "opioid causes seizures" story. Opioids themselves generally raise the seizure threshold rather than lower it. The problem lies in the promethazine component and in what happens when either drug is suddenly removed.
Promethazine lowers the seizure threshold when it accumulates in the blood. It also blocks fast sodium channels in neurons at high concentrations, which can produce abnormal electrical firing. In plain terms: the antihistamine in lean is the ingredient most directly linked to seizure activity, not the codeine.
The brain's seizure threshold is the level of stimulation needed to trigger an uncontrolled electrical discharge. Every drug that crosses into the brain can shift that threshold up or down. Lean shifts it in both directions depending on dose and timing.
Promethazine's sedative effect also causes deep sleep, and sudden awakening from deep sedation can occasionally provoke seizures in susceptible people. This is a rare but documented phenomenon in sedative-hypnotic drugs. The mechanism involves abrupt changes in cortical excitability as the brain transitions between sleep stages.
Quantified Seizure Risk From Each Ingredient
The numbers vary widely by ingredient and scenario. A standard prescription-strength lean dose is 10 to 20 mg of codeine combined with 6.25 to 12.5 mg of promethazine per ounce. Recreational users often consume 8 to 16 ounces, which delivers 80 to 320 mg of codeine and 50 to 200 mg of promethazine.
Promethazine toxicity thresholds are well established. Seizures are reported at doses above 100 mg, and the risk rises sharply above 200 mg. One toxicology analysis found that 1 to 10 percent of serious promethazine poisonings involve seizures. Dystonia, an involuntary muscle contraction, occurs in about 1 to 5 percent of overdose cases and can be mistaken for a seizure.
Codeine alone rarely causes seizures. The drug's lethal risk in overdose is respiratory depression, not convulsion. The threshold for codeine toxicity is generally above 400 mg in a non-tolerant adult, and seizures are not a typical feature of that toxidrome.
Fentanyl contamination changes the calculus entirely. Illicit fentanyl is now found in a significant share of street-sold opioid products. The exact percentage varies by region and year, but public health surveys in multiple US states have reported fentanyl in 30 to 70 percent of tested counterfeit opioid samples. Fentanyl does not usually cause seizures, but the withdrawal from it can.
The most cited figure is the naloxone reversal threshold: 0.4 mg to 2 mg intranasal, repeated every 2 to 3 minutes. This is relevant because severe respiratory depression is often the event that precedes a seizure in opioid overdose, not the seizure itself.
The Withdrawal Seizure Pathway
Withdrawal is the most plausible route from lean to a seizure in an otherwise healthy user. The mechanism is well understood in alcohol and benzodiazepine withdrawal, and it applies to any sedative the brain has adapted to. When a regular user stops, the brain's excitatory systems, which were suppressed by the drug, become unopposed.
Opioid withdrawal alone does not typically cause seizures. The classic opioid withdrawal syndrome includes anxiety, sweating, vomiting, diarrhea, and muscle cramps, but convulsions are not a standard feature. Benzodiazepine and alcohol withdrawal are the seizure-prone ones, with seizure risk starting at 6 to 48 hours after the last dose.
Lean is frequently cut with benzodiazepines, and that is the underrecognized danger. Promethazine itself has weak anticholinergic properties and can accumulate with repeated dosing. If a user has also been taking benzodiazepines or alcohol alongside lean, stopping all three at once produces a combined withdrawal state with a much higher seizure risk.
The timeline matters. Seizures from sedative withdrawal typically cluster in the first 12 to 48 hours. Opioid withdrawal peaks at 48 to 72 hours and is not the seizure window. This distinction is critical for anyone assessing risk.
Timeline of Lean-Related Seizure Risk
| Time after last dose | What is happening | Seizure risk level |
|---|---|---|
| 0 to 6 hours | Drug still active; sedation and respiratory depression dominate | Low, unless overdose or contaminated product |
| 6 to 12 hours | Early withdrawal begins if dependent; anxiety and tremor | Low to moderate |
| 12 to 24 hours | Peak sedative-withdrawal window if benzodiazepines or alcohol involved | Moderate to high |
| 24 to 48 hours | Seizure risk from combined sedative withdrawal remains elevated | Moderate to high |
| 48 to 72 hours | Opioid withdrawal peak; gastrointestinal symptoms dominate | Low for seizures, high for distress |
| 72 to 96 hours | Withdrawal begins to resolve | Low |
| 4 to 7 days | Acute withdrawal largely over; sleep and mood still disturbed | Very low |
| 1 to 4 weeks | Post-acute phase; sleep deprivation and anxiety persist | Low, but sleep loss can lower threshold |
The table above reconciles the key windows. Seizure risk peaks between 12 and 48 hours, not during intoxication, and the driver is sedative withdrawal rather than opioid withdrawal. Users who take lean alongside benzodiazepines or alcohol face the highest risk in that 12-to-48-hour window.
Sleep Deprivation and Binge Patterns
Sleep deprivation is a genuine, measurable seizure trigger. Prolonged wakefulness lowers the seizure threshold in both animal models and human studies. A single night of total sleep deprivation can provoke seizures in people with epilepsy, and repeated poor sleep is one of the most commonly reported triggers.
Lean binges promote exactly the pattern that produces sleep debt. Users stay awake while sedated, sleep in fragmented blocks, and often go 24 to 48 hours with poor rest. The combination of sedative withdrawal and sleep deprivation can produce a seizure in a person who has never had one before.
This mechanism is not unique to lean. It applies to any sedative-hypnotic cycle, which is why clinicians treating withdrawal emphasize sleep hygiene as a seizure-prevention measure, not only medication.
In plain terms: staying awake for a long stretch while coming off a sedative is one of the riskiest combinations for a first-time seizure. The stimulant effect of the setting, the fragmented sleep, and the withdrawal all compound.
Adulterants That Change the Answer
The real-world answer to "can lean cause seizures" depends heavily on what is actually in the bottle. Lean bought outside a pharmacy is not reliably codeine and promethazine. Common adulterants include promethazine at much higher doses, dextromethorphan, benzodiazepines, and fentanyl.
Dextromethorphan is a genuine seizure risk at high doses. It is a dissociative drug at supratherapeutic levels and has been linked to seizures in overdose. Products sold as lean sometimes contain dextromethorphan instead of codeine, and users may not know.
Benzodiazepine adulteration is the most important hidden risk. A benzo-laced lean product produces dependence that the user does not attribute to lean. When they stop lean, they enter benzodiazepine withdrawal without knowing it, which is the highest-seizure-risk withdrawal state among common sedatives.
Ivermectin and other non-opioid adulterants have been found in counterfeit cough syrup in some regions, but the evidence for seizure causation is weak. The practical point is that the contents are unknown, so risk cannot be estimated from the label.
What the Evidence Establishes vs. What Remains Hypothesis
The established evidence is that promethazine overdose causes seizures in a meaningful fraction of serious cases, that sedative withdrawal causes seizures, and that sleep deprivation lowers the seizure threshold. These are supported by toxicology reviews and withdrawal literature.
The hypothesis, not yet proven, is that recreational lean use in a person without epilepsy produces a first seizure through a combined mechanism. Case reports exist, but large cohort data do not. This is a real gap, and it should temper any claim of a precise percentage.
What is not supported is the idea that a normal, single dose of lean causes a seizure in a healthy adult. At prescription doses of 10 to 20 mg codeine and 6.25 to 12.5 mg promethazine per ounce, the seizure risk is negligible in people without a seizure disorder.
Comparison: Lean vs. Other Seizure-Linked Substances
| Substance | Typical seizure mechanism | Typical seizure window | Approximate risk context |
|---|---|---|---|
| Lean (codeine + promethazine) | Promethazine toxicity; sedative withdrawal | 12 to 48 hours after stopping, or at high dose | Low at prescription dose; higher with adulterants |
| Alcohol | Withdrawal | 6 to 48 hours after last drink | Seizures in 5 to 15 percent of severe withdrawal cases |
| Benzodiazepines | Withdrawal | 1 to 4 days after last dose | High in dependent users |
| Tramadol | Serotonergic and opioid effects | During use, at high dose | Seizure risk notable above 400 mg/day |
| Bupropion | Dose-dependent threshold lowering | During use, at high dose | Seizures above 450 mg/day |
The comparison shows that lean's mechanism resembles alcohol and benzodiazepine withdrawal more than it resembles opioid toxicity. That distinction matters for prevention, because the actions that prevent withdrawal seizures are different from the actions that prevent opioid overdose.
Red Flags That Require Emergency Help
- A seizure lasting more than 5 minutes, or repeated seizures without recovery between them.
- Confusion, stiff neck, or fever after a seizure, which can indicate infection or another cause.
- Seizure in someone who has taken lean and also drinks alcohol or takes benzodiazepines.
- Breathing slower than 8 breaths per minute, or blue lips, which signals opioid overdose, not seizure.
- A first-ever seizure in anyone, which requires medical evaluation regardless of cause.
- Seizure accompanied by a head injury or fall.
These signs should trigger a call to emergency services. Naloxone can reverse opioid-related respiratory depression but does not treat a seizure, and it should not delay emergency care.
What to Actually Do
If you use lean and want to reduce seizure risk, the most effective steps target withdrawal and sleep, not the drug itself. Tapering rather than stopping abruptly is the single most important action, and it applies to any sedative the user has taken regularly.
- Taper codeine and promethazine slowly over one to two weeks rather than stopping cold.
- Screen for hidden benzodiazepine use before tapering, and if present, seek medical supervision for that taper first.
- Protect sleep during and after use; aim for 7 to 9 hours per night and avoid all-night binges.
- Avoid combining lean with alcohol, benzodiazepines, or other sedatives, which multiplies withdrawal seizure risk.
- Test products where fentanyl test strips are available, and never use alone.
- Seek medical advice before stopping any sedative used daily for more than a few weeks.
If a seizure occurs, the immediate action is to protect the person from injury, place them on their side, and call emergency services. Do not restrain them or put anything in their mouth. After the seizure, medical evaluation is required.
Limitations of the Current Evidence
The biggest limitation is the absence of large studies on recreational lean use. Most data come from prescription promethazine overdose, which may not match recreational dosing patterns. The adulterant problem also means the product studied is rarely the product used.
Seizure risk estimates for promethazine are drawn from poison center data, which undercount mild cases and overcount severe ones. The true rate in casual users is almost certainly lower than the 1 to 10 percent figure for serious overdose.
Finally, individual susceptibility varies enormously. A person with a prior head injury, a family history of epilepsy, or a low seizure threshold faces a different risk than the average user. No single percentage applies to everyone, so the practical answer remains: risk is low but not zero, and it concentrates in withdrawal, high doses, and contaminated products.